Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Clinical trial NCT00094055 · COMPLETED

Trial details

NCT number: NCT00094055
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thyroid Neoplasms

Start date: 2004-09-01
Primary completion: 2009-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.